Headlands is heading to the ADA 2026 Scientific Sessions, June 5–8, in New Orleans. We’re looking forward to engaging with the community, exploring the latest advancements, and continuing conversations that move diabetes research forward.
If you’ll be at the ADA 2026 Scientific Sessions, schedule a time to connect with one of our experts:
- Christopher Romero, Medical Director and Principal Investigator at Headlands Research Brownsville
- Larry Sher, Associate Medical Director and Principal Investigator at Headlands Peninsula Research Associates
- Jenine Yager Stone, Principal Investigator at Headlands Research AMCR Institute
- Josh Devine, Therapeutic Area Lead Manager - Cardiometabolic
- Tori Wallenburg, Director of Strategy & Channel Alliances